Company Analysis

Plus Therapeutics, Inc. (PSTV)

Nasdaq: PSTV · Surgical & Medical Instruments & Apparatus · Austin, TX · filing with the SEC since 2001
Grade2.9
◀ Past 1.3● Present 2.7▶ Future 4.7
1 est.

Who runs Plus Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Hedrick Marc H
Chief Executive Officer. First filing Jan 2006, latest Oct 1, 2026, 13 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
23 people on the record since 2006
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Andrews Ronald AsburyChief Business OfficerMar 2026Nov 12, 2026none
Hedrick Marc HChief Executive OfficerJan 2006Oct 1, 2026none
Sims Andrew John Hugh MacintyreChief Financial OfficerFeb 2020Oct 1, 2026none
Daniels Eric JosephChief Development OfficerApr 2026Apr 22, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Clowes HowarddirectorApr 2020Oct 1, 2026none
Guse KyledirectorAug 2025Oct 1, 2026none
Hawkins Richard JdirectorDec 2007Oct 1, 2026none
Van Es-Johansson AndirectorJan 2020Oct 1, 2026none
Lenk Robert PdirectorApr 2020Aug 25, 2025none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PSTV · research, not advice